BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3016449)

  • 1. Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
    Ukena D; Shamim MT; Padgett W; Daly JW
    Life Sci; 1986 Aug; 39(8):743-50. PubMed ID: 3016449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors.
    Ukena D; Olsson RA; Daly JW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):365-76. PubMed ID: 3580959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
    J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
    Ukena D; Daly JW; Kirk KL; Jacobson KA
    Life Sci; 1986 Mar; 38(9):797-807. PubMed ID: 3005794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D; Padgett WL; Hong O; Daly JW; Daly DT; Olsson RA
    FEBS Lett; 1987 May; 215(2):203-8. PubMed ID: 3582647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U; Ukena D; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of adenosine A2 receptor in PC12 cells.
    Noronha-Blob L; Marshall RP; Kinnier WJ; U'Prichard DC
    Life Sci; 1986 Sep; 39(12):1059-67. PubMed ID: 3018408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine analogs: structure-activity relationships at adenosine receptors.
    Daly JW; Hide I; Müller CE; Shamim M
    Pharmacology; 1991; 42(6):309-21. PubMed ID: 1658821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT; Ukena D; Padgett WL; Daly JW
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazodiazepinediones: a new class of adenosine receptor antagonists.
    Daly JW; Hide I; Bridson PK
    J Med Chem; 1990 Oct; 33(10):2818-21. PubMed ID: 2213834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.
    Ukena D; Böhme E; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):36-42. PubMed ID: 6092968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW; Padgett WL; Shamim MT
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonists.
    Daly JW; Padgett WL; Eger K
    Biochem Pharmacol; 1988 Oct; 37(19):3749-53. PubMed ID: 3178888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase.
    Daly JW; Padgett WL
    Biochem Pharmacol; 1992 Mar; 43(5):1089-93. PubMed ID: 1554381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW; Jacobson KA; Ukena D
    Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors.
    Cristalli G; Eleuteri A; Vittori S; Volpini R; Lohse MJ; Klotz KN
    J Med Chem; 1992 Jun; 35(13):2363-8. PubMed ID: 1619615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Green RM; Stiles GL
    J Clin Invest; 1986 Jan; 77(1):222-7. PubMed ID: 3003150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors.
    Lohse MJ; Klotz KN; Schwabe U; Cristalli G; Vittori S; Grifantini M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):687-9. PubMed ID: 3216901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of adenosine analogs on PC12 cells.
    Guroff G; Dickens G; End D; Londos C
    J Neurochem; 1981 Dec; 37(6):1431-9. PubMed ID: 7334372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.